Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0019158 (hepatitis)
 30,205 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

It is reported on the dispensary care of 789 patients suffering from infectious hepatitis. Of these patients 92.86% healed completely of hepatitis during observation. 2.91% developed sequels after hepatitis, among them 1.03% a posthepatitic hyperbilirubinaemia, 1.03% a chronic persistent hepatitis, 0.17% a chronic aggressive hepatitis, 0.34% a liver cirrhosis, 4.25% had concomitant diseases, such as fatty degeneration of the liver, diseases of the bile duct, pancreatitis, and ventricular ulcer. The probable associations of these diseases with infectious hepatitis are discussed. Three patients suffered from diabetes mellitus. One of these patients developed a chronic aggressive hepatitis and finally an incipient cirrhosis.
 ...
PMID:[Results of 10 years hepatitis follow-up]. 87 28

40 patients with infectious hepatitis, 25 with chronic aggressive hepatitis, 25 with compensated liver cirrhosis, and 10 with decompensated liver cirrhosis were submitted to examination. The following abnormalities depending upon the stage and severity of hepatic diseases were found: a) disturbances of total lipids, cholesterol, phospholipids, beta-lipoproteids, glycerin, glycerides and neutral fats concentrations; b) marked disorders of glucose tolerance as indicated by the difference between plasma and erythrocyte glucose levels increasing in proportion to the degree of liver damage; c) a fall in plasma and erythrocyte magnesium reflecting the degree of hepatic parenchyma damage; d) a decrease of the albumin/gamma-globulin ratio in proportion to the degree of the impairment of hepatic cells. The presented fat, carbohydrate, magnesium and protein balance indices yield better criterions for the differential diagnostics of hepatic diseases than the routine investigations, and they also make possible objective prognosis.
 ...
PMID:Disturbances of fat, carbohydrate, magnesium and protein balance in liver diseases. 88 63

The occurrence of infectious hepatitis in patients with coexistent glucose-6-phosphate dehydrogenase (G6PD) deficiency may present a clinical picture similar to that of fulminant hepatitis. To determine the factors which enable a rapid diagnosis of this disease combination, the clinical and biochemical findings in 14 patients were compared with those in 50 patients with uncomplicated hepatitis and those in 14 patients with fulminant hepatitis. Similarities with the latter group included persistence of fever, tachycardia, leukocytosis and hyperbilirubinemia of greater than 340 mumol/liter (20 mg/dl). A rise in bilirubin values of more than 50 mumol/liter (3 mg/dl) per day in patients with viral hepatitis strongly suggested the presence of G6PD deficiency. Despite the severity of the illness, prothrombin activity was well maintained in G6PD-deficienct patients.
 ...
PMID:Infectious hepatitis and glucose-6-phosphate dehydrogenase deficiency. 88 12

In the Tri-State Leukemia Survey, the history of diseases in 605 adult male leukemia cases 15 years and older and in 668 adult male population controls was examined. These diseases occurred at least 1 year before leukemia was diagnosed. The data were based on respondents' answers that the disease was diagnosed by a physician; the respondent was either the subject or his spouse. Of 30 diseases studied, 7 showed an excess among the patients with leukemia: infectious hepatitis, eczema, psoriasis, diabetes, arthritis and rheumatism, heart disease, and ankylosing spondylitis. Mumps had a lower reported occurrence among the cases, whereas pneumonia was less frequent in acute lymphatic cases than in population controls. Three diseases occurred significantly less in controls than in persons with specific histologic types of leukemia. Our data revealed a more frequent history of herpes zoster (shingles) in chronic lymphatic leukemia, more hives in acute chronic myeloid cases, and meningitis in acute myeloid leukemia. When we only considered the patients' responses, more of them admitted having had acne than did our controls. The remaining diseases--childhood viral diseases, infectious mononucleosis, smallpox, typhoid fever, dysentery, scarlet fever, tuberculosis, asthma, hay fever, and goiter did not occur more frequently in cases than in controls. The findings were consistent with evidence from previous laboratory and clinical studies. The increased occurrence of infectious hepatitis in our case series is consistent with the findings of other studies showing an increased frequency of Australia antigen in patients with hepatitis, leukemia, and Down's syndrome.
 ...
PMID:Epidemiology of diseases in adult males with leukemia. 99 1

One hundred and fifty-two biopsies from serologically HBsAg positive and negative patients with liver disease were studied in immunofluorescence: for the presence of the surface (HBs) and the core (HBc) antigenic determinants foeterminants of the hepatitis B virus, of immunoglobulins and complement (C) deposits, and for the capacity to fix human C. Circumstantial evidence is presented suggesting that HBc immune-complexes are a relevant feature in the establishment and progression of chronic HBSAg liver disease. C fixation by liver cells was shown in all HBC positive patients with chronic hepatitis; an active form was present in every case, except two with a persistent hepatitis, an inverse ratio of HBc to C binding fluorescence being noted between active chronic hepatitis and cirrhotic patients. HBc without C fixation was observed in only three patients in the incubation phase of infectious hepatitis. IgG deposits were often found in HBc containing, C fixing nuclei. No C binding or IgG deposits were observed in acute self-limited type B hepatitis, in serologically positive patients with normal liver or minimal histological lesions, with and without HBs cytoplasmic fluorescence in their biopsy, or in serologically negative individuals.
 ...
PMID:Complement fixing hepatitis B core antigen immune complexes in the liver of patients with HBs antigen positive chronic disease. 100 73

Eighty-five patients notified to the local medical officer of health as infectious or serum hepatitis during the period 1 September 1974-1 September 1975 were investigated by questionnaire. Serum from 73 cases was tested for the presence of HBsAg. Sixteen cases were notified as serum hepatitis but only 13 were shown to have HBsAg in their serum. Sixty-eight cases were notified as infectious hepatitis and 21 HBsAg positive cases were found amongst the 57 sera tested. Two-thirds of the HBsAg positive cases were not suspected clinically. The epidemiology of hepatitis in Christchurch is discussed and suggestion is made that all notified cases of hepatitis should have blood tested for HBsAg.
 ...
PMID:Hepatitis B surface antigen in notified cases of viral hepatitis. 106 82

A patient of 50 years is admitted to hospital. He is found to be suffering from infectious hepatitis complicated by thrombocytopenia, the initial platelet count being 10 000 per mul soon falling to 2000 per mul. A prompt increase in the number of platelets is seen during treatment with prednisone, but a sudden fall is observed after a gradual reduction of prednisone to zero, the reaction for hepatitis associated antigen at that point still being positive. After a renewed therapy with adrenocortical steroid, the platelet count is within normal limits, and the patient is discharged with a small dose of prednisone. At the time of discharging, the HAA reaction had been negative for 3 weeks. After treatment with a small dose of prednisone for 2 months, the patient was taken into hospital. In the course of one week the dose of prednisone was gradually reduced without any fall in the platelet count. The possibility of lysis of a platelet-virus antigen as an explanation of thrombocytopenia complicating infectious hepatitis is discussed.
 ...
PMID:Thrombocytopenia complicating infectious hepatitis. 113 Jan 62

The AA. carrie out an analysis of the results obtained by means of the radioimmunologic method and concludes as follows: 1) Au-positive acute hepatitis represent the more largely diffused form among adult people; 2) from a clinical point of view, it seems appropriate to modify definitions of A and B hepatitis, of infectious hepatitis or serum hepatitis, classifying this disease as follows: a) hepatitis with positive antigenemy; b) hepatitis with negative antigenemy; and this independently from the anamnestic and epidemiologic elements. In the second part of this report, the AA., after introducing some considerations on the effects of the therapy by means of steroids, illustrate the data concerning a study carried out on a group of Au-positive and Au-negative subjects, subdivided into treated and non treated patients. From these analysis, even if a statistical survey has not been made, no elements are noticed, able to differentiate the behaviour of the two groups of hepatitis studied, in comparison with the therapy by means of steroids. One single Au-negative case, within a certain period of time, after the therapy with steroids, showed the presence of a positivity of immunologic phenomena only by the radioimmunoassay.
 ...
PMID:[Radioimmunologic determination of hepatitis antigen and its clinical implications]. 122 56

We report a case of clinical hepatitis associated with occupational exposure to halothane in a research laboratory. A biochemist who for 3 y repeatedly used halothane for sedation and euthanization of rats suffered recurrent episodes of epigastric discomfort, culminating in an episode of malaise, anorexia, jaundice and elevated liver associated enzymes that promptly resolved after removal from exposure to halothane. Serologic testing for viral sources and risk factors for non-infectious hepatitis were negative. Halothane-induced hepatitis has been documented as an idiosyncratic reaction among anesthetized patients and has been reported once in operating room personnel. The mechanism for halothane-induced hepatitis is proposed to be a hypersensitivity reaction to liver neo-antigens produced by the halothane metabolite 2-chloro-1, 1, 1-trifluoroethane.
 ...
PMID:Chemical hepatitis associated with occupational exposure to halothane in a research laboratory. 145 11

ELISA detection of a hepatitis-E-virus-associated antigen (HEV-AAg) in stools was reappraised for its possible interference with a new Fab-binding factor, termed protein Fv, released during infectious hepatitis. Transaminase elevation, HEV-AAg discharge and Fv leakage appeared simultaneously in a Cercopithecus monkey inoculated with infected stools. Labelled normal, or immune human IgG, were compared with pre- and post-inoculation simian IgG, for HEV-AAg and Fv detection. Coated normal and patient human IgM were also compared to pre- and post-inoculation simian IgM in HEV-AAg and Fv capture assays. Simian IgM and beta-galactosidase-labelled simian IgG minimized Fv interference and appeared to be the best adapted system for HEV-AAg detection. Nevertheless, Fv was still the cause of false-positive interpretations in some cases; therefore adsorption with monoclonal IgM was required to ensure HEV specificity. The improved test was performed on stools from 30 Senegalese patients hospitalized for various sporadic attacks of viral hepatitis. HEV-AAg was detected in 6 out of 30 cases and no positivity was observed in patients suffering from hepatitis due to HAV, HBV, cytomegalovirus or Epstein-Barr virus. The specificity of the assay was confirmed by inhibition experiments with the sera from HEV-infected patients. Hence, this inhibition assay can also be used to detect serum antibodies to HEV-AAg.
 ...
PMID:Hepatitis-E-virus-associated antigen: improved detection in stools by protein Fv removal. 166 35


<< Previous 1 2 3 4 5 6 7 8 9 Next >>